Understanding EGFR heterogeneity in lung cancer

Understanding EGFR heterogeneity in lung cancer

The advances in understanding the inherited biological mechanisms of non-small cell lung cancer harbouring epidermal growth factor receptor (EGFR) mutations led to a significant improvement in the outcomes of patients treated with EGFR tyrosine kinase inhibitors. Despite these clinically impressive...

Full description

Bibliographic Details
Main Authors: Francesco Pepe, Umberto Malapelle, Giancarlo Troncone, Caterina De Luca, Pasquale Pisapia, Alessandro Russo, Christian Rolfo, Caterina Fumagalli, Elena Guerini-Rocco, Antonio Passaro, Filippo de Marinis, Marzia Del Re, Ilaria Attili, Federico Cucchiara, Romano Danesi, Lorenzo Spaggiari
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/5/e000919.full

Internet

https://esmoopen.bmj.com/content/5/5/e000919.full

Similar Items